(1α,2β,4β,5α,7β)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-di-methyl-3-oxa-9-azoniatricyclo[3.3.1.0]nonane bromide (1α,2β,4β,5α,7β)-7-[2-羟基-2,2-二(2-噻吩基)乙酰氧]-9,9-二甲基-3-氧杂-9-氮阳离子三环[3.3.1.0]壬烷溴化物
CAS 136310-93-5 MFCD00867027
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Heterocycles
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Sulfur & Selenium Compounds,
产品应用
- Muscarinic receptor antagonist. Bronchodilator.
相关文献及参考
- [2]. ZuWallack AR, ZuWallack RL. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease. Expert Opin Pharmacother. 2004 Aug;5(8):1827-35.
- [3]. Lipson DA. Tiotropium bromide. Int J Chron Obstruct Pulmon Dis. 2006;1(2):107-14.
- [4]. Mamary AJ, Criner GJ. Tiotropium bromide for chronic obstructive pulmonary disease. Expert Rev Respir Med. 2009 Jun;3(3):211-20.
- [5]. Szmidt M. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)]. Pneumonol Alergol Pol. 2012;80(3):255-62.
- Donohue, J. F., et al.: Chest, 122, 47 (2002),
- Haddad, E.-B., et al.: Mol. Pharmacol., 45, 899 (1994),
- Profita, M., et al.: Allergy, 60, 1361 (2005),
- [1]. Barnes PJ. Tiotropium
